Replies to post #159254 on Biotech Values

[JJM760]

Someone is not being truthful. I hope for my sake its not Ariad. See you tomorrow.

[biotech_researcher]

The update on Ariad '113 this morning is very intriguing. I would expect we are at the point in starting the ph II portion of the '113 trial. If, as Ariad has wanted to do all along, they can start both the ALK+ and EGFR trial at the same dose, this Adam F and Favus fiasco will soon fade.